These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new ...

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

Researchers looked at the nine people who had vision problems while using the drugs and is one of several that have ...

Among over 125,000 patients, 53.6% discontinued their GLP-1 receptor agonist by 1 year, and these rates were significantly ...

Share on Pinterest Women with diabetes may get the strongest ... “Both SGLT2 inhibitors and GLP-1 agonists are excellent drug categories that have improved the heart health of patients by ...

A majority with overweight/obesity discontinue within a year, but the rate is higher among those without type 2 diabetes.

Learn about the financial strain caused by the skyrocketing demand and costs of GLP-1 drugs, and how health plans and providers are struggling to balance it.

WVU Medicine is playing a lead role in a national clinical study of a minimally invasive surgical procedure for people who've ...

Groundbreaking research reveals how common diabetes medications might offer unprecedented protection against heart attacks and strokes in survivors.

A small percentage of patients taking the extraordinarily popular GLP-1 medications have experienced vision problems, but a ...

A recent review shows who newer medications for type 2 diabetes may help the most, particularly in reducing the risk of cardiovascular disease.